Cell Free Protein Synthesis Market - Global Forecast To 2030
商品番号 : SMB-90493
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年10月 |
| ページ数 | 309 |
| 図表数 | 470 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
無細胞タンパク質合成市場 – 提供製品（細胞抽出システム（原核生物、哺乳類、植物）、キット、機器、サービス）、ワークフロー、方法（結合TX/TL、転写、翻訳）、用途（タンパク質精製） – 2030年までの世界予測
無細胞タンパク質合成市場は、2025年の2億1,720万米ドルから2030年には3億890万米ドルに達すると予測されており、予測期間中の年平均成長率（CAGR）は7.3%です。この市場の成長は、迅速かつ効率的なタンパク質生産に対する需要の高まり、再構成無細胞システムの採用拡大、合成生物学および創薬における用途拡大、毒性が高く発現が困難なタンパク質の発現ニーズ、そして発現システムを最適化するためのAI/MLの統合によって牽引されています。
この調査レポートでは、無細胞タンパク質合成市場を、提供内容（発現システム、試薬、機器などの製品）、サービス、ワークフロー段階（テンプレートの準備、反応のセットアップ、転写と翻訳、タンパク質の折り畳みと翻訳後修飾、回収と精製、検証と分析）、方法（転写と翻訳の結合、翻訳のみ）、用途（酵素工学、ハイスループット生産、タンパク質の標識付け、タンパク質の精製、タンパク質間相互作用）、エンドユーザー（学術機関、研究機関、製薬会社、バイオテクノロジー企業、その他）、地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）別に分類しています。
本レポートは、無細胞タンパク質合成市場の成長に影響を与える主要な要因、すなわち成長促進要因、トレンド、課題、機会に関する詳細な情報を提供しています。主要業界プレーヤーを包括的に分析し、各社の事業概要、製品・サービス、主要戦略、協業、パートナーシップ、契約内容に関する洞察を提供しています。また、無細胞タンパク質合成市場における新製品の発売や買収といった最近の動向についても取り上げています。
本レポートは、無細胞タンパク質合成市場全体とそのセグメントの収益に関する詳細な推定値を提供することで、市場リーダー企業と新規参入企業を支援します。また、ステークホルダーが競争環境をより深く理解し、より効果的な事業ポジショニングと適切な市場開拓戦略の策定に役立つ洞察を得るのに役立ちます。本レポートは、ステークホルダーが市場の現状を把握し、主要な推進要因、制約要因、機会、課題に関する情報を提供します。
本レポートでは、以下の点について洞察を提供しています。
市場の成長に影響を与える主要な推進要因（研究・製薬業界における迅速なタンパク質合成の需要増加、毒性が高く発現が困難なタンパク質の需要増加、CFPSを用いたタンパク質工学におけるAI/MLの統合）、制約要因（必須試薬の高コスト）、機会（バイオセンサー開発における無細胞技術の統合、無細胞タンパク質発現の商業規模での検証）、課題（複雑な哺乳類の翻訳後修飾を完全に再現できないこと）の分析。
- 製品開発／イノベーション：無細胞タンパク質合成市場における新製品／サービスに関する詳細な洞察
- 市場開発：収益性の高い市場に関する包括的な情報 – 本レポートでは、様々な地域にわたる市場分析を行っています。
- 市場多様化：無細胞タンパク質合成市場における新製品、未開拓地域、最近の開発状況、投資に関する包括的な情報
- 競合評価：無細胞タンパク質合成市場における主要企業（New England Biolabs（米国）、Thermo Fisher Scientific Inc.（米国）、Takara Bio, Inc.（日本）、Promega Corporation（米国）など）の市場シェアと成長戦略に関する詳細な評価
Report Description
The cell-free protein synthesis market is projected to reach USD 308.9 million by 2030, up from USD 217.2 million in 2025, with a CAGR of 7.3% during the forecast period. Growth in this market is driven by increasing demand for rapid and efficient protein production, rising adoption of reconstituted cell-free systems, expanding applications in synthetic biology and drug discovery, the need to express toxic and difficult-to-express proteins, and the integration of AI/ML to optimize expression systems.
The cell-free protein synthesis services experienced the fastest growth during the forecast period of 2025 to 2030.
The cell-free protein synthesis market is divided into offerings such as products—like expression systems, reagents, and instruments—and services. During the forecast period, cell-free protein synthesis services are expected to grow the fastest due to increasing demand for customized protein production solutions, the need for quick prototyping, and the rising adoption of outsourcing by academic institutions and biotech companies. These services enable researchers to access advanced CFPS technologies without investing in expensive infrastructure or expertise. Growing interest in contract-based protein expression for drug discovery, synthetic biology, vaccine development, and proteomics is fueling demand. Additionally, the increasing complexity of protein targets, including toxic, unstable, or membrane proteins, is encouraging more organizations to turn to specialized service providers who can deliver high-quality proteins quickly and efficiently.
Enzyme engineering is a key application of cell-free protein synthesis, dominating the CFPS market.
The CFPS market, categorized by application, includes enzyme engineering, high-throughput protein production, protein labeling, protein purification, and studies of protein–protein interactions. In 2024, enzyme engineering dominated the CFPS application market due to its extensive use in research areas like synthetic biology, pathway prototyping, directed evolution, and therapeutic antibody development. CFPS enables researchers to rapidly test and optimize enzymes without the need for living cells, making it ideal for designing enzymes with enhanced performance, stability, and specificity. Additionally, it supports the creation of new biocatalysts, improves metabolic pathways, and accelerates drug discovery. The increasing demand for faster, scalable, and flexible protein production in pharmaceuticals, biotechnology, and other sectors ensures that enzyme engineering will remain the primary growth driver in the CFPS market.
The Asia Pacific region will experience the highest CAGR in the cell-free protein synthesis market during the forecast period of 2025 to 2030.
Asia Pacific is projected to have the highest CAGR in the cell-free protein synthesis market during the forecast period, fueled by increasing investments in biotechnology research, growing pharmaceutical manufacturing, and a rising focus on synthetic biology and precision medicine in the region. Countries such as China, Japan, South Korea, and India are significantly boosting their R&D capabilities through government funding, public–private partnerships, and international collaborations, creating strong demand for CFPS technologies. The growing adoption of high-throughput protein production, enzyme engineering, and rapid prototyping in drug discovery, vaccine development, and diagnostics continues to drive market growth. Additionally, the region benefits from a large, skilled workforce, lower production costs, expanding contract research organizations (CROs), and improving research infrastructure, establishing Asia Pacific as a high-potential growth market for cell-free protein synthesis.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
- By Designation: (Managers) – 45%, (CXOs, Directors)- 30%, and (Executives) – 25%
- By Region: North America- 40%, Europe – 25%, Asia Pacific – 20%, Rest of the World – 15%
Promega Corporation (US), New England Biolabs (US), Thermo Fisher Scientific Inc. (US), Genscript (US), and Takara Bio Inc. (Japan) are among the major players in the cell-free protein synthesis market.
The study provides a detailed competitive analysis of these key players in the cell-free protein synthesis market, including their company profiles, recent updates, and main market strategies.
Research Coverage:
This research report categorizes the cell-free protein synthesis market by offering (products such as Expression Systems, Reagents, and Instruments), services, workflow stages (Template preparation, Reaction setup, Transcription and translation, Protein folding and post-translational modification, Recovery and purification, Validation and analysis), method (Coupled Transcription-Translation, Only Translation), application (Enzyme Engineering, High-Throughput Production, Protein Labeling, Protein Purification, Protein–Protein Interaction), end user (academic and research institutes, pharmaceutical and biotechnology companies, others), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The report offers detailed information on key factors affecting the growth of the cell-free protein synthesis market, including drivers, trends, challenges, and opportunities. A comprehensive analysis of major industry players has been conducted to provide insights into their business profiles, products or services offered, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments such as new product launches and acquisitions within the cell-free protein synthesis market.
Key Benefits of Buying the Report:
The report will assist market leaders and newcomers by offering close estimates of revenue figures for the overall cell-free protein synthesis market and its segments. It will also help stakeholders better understand the competitive landscape and gain insights to more effectively position their business and develop appropriate go-to-market strategies. This report will allow stakeholders to grasp the market’s current state and provide information on key drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (Increasing demand for rapid protein synthesis in research and pharma, growing demand for toxic and difficult-to-express proteins, integration of AI/ML for protein engineering using CFPS), restraints (high cost of essential reagents), opportunities (integration of cell-free technology in biosensors development, commercial-scale validation of cell-free protein expression) and challenges (Inability to fully replicate complex mammalian post‑translational modifications) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products/services in the cell-free protein synthesis market
- Market Development: Comprehensive information about lucrative markets – the report analyzes the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-free protein synthesis market
- Competitive Assessment: In-depth assessment of market share, growth strategies of leading players like New England Biolabs (US), Thermo Fisher Scientific Inc. (US), Takara Bio, Inc. (Japan), and Promega Corporation (US), among others, in the cell-free protein synthesis market
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 35
1.3.2 INCLUSIONS AND EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.4 CURRENCY CONSIDERED 37
1.5 STAKEHOLDERS 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
2.1.1 SECONDARY DATA 38
2.1.1.1 Key sources of secondary data 38
2.1.1.2 Key objectives of secondary research 39
2.1.2 PRIMARY DATA 39
2.1.2.1 Breakdown of primaries 40
2.1.2.2 Key objectives of primary research 40
2.2 MARKET SIZE ESTIMATION 41
2.2.1 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET ESTIMATION, 2024 41
2.2.1.1 Company revenue analysis (bottom-up approach) 41
2.2.1.2 MnM repository analysis 42
2.2.1.3 Primary research 43
2.2.1.3.1 Insights from primary experts 43
2.2.2 SEGMENTAL MARKET SIZE ESTIMATION (TOP–DOWN APPROACH) 44
2.3 MARKET GROWTH RATE PROJECTIONS 45
2.4 DATA TRIANGULATION 47
2.5 STUDY ASSUMPTIONS 47
2.6 RESEARCH LIMITATIONS 48
2.7 RISK ANALYSIS 49
3 EXECUTIVE SUMMARY 50
3.1 KEY INSIGHTS & MARKET HIGHLIGHTS 50
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS IN CELL-FREE PROTEIN SYNTHESIS MARKET 54
3.3 DISRUPTIVE TRENDS SHAPING CELL-FREE PROTEIN SYNTHESIS MARKET 54
3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 55
4 PREMIUM INSIGHTS 56
4.1 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET SNAPSHOT 56
4.2 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION AND COUNTRY, 2024 57
4.3 CELL-FREE PROTEIN SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
4.4 UNMET NEEDS & WHITE SPACES 58
4.5 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 59
4.6 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS 59
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
5.2.1 DRIVERS 62
5.2.1.1 Increasing demand for rapid protein synthesis for research
and therapeutic applications 62
5.2.1.2 Momentum from biologics/ADC pipelines adopting CFPS
for site-specific conjugation 63
5.2.1.3 Ability to express difficult/complex proteins 63
5.2.2 COMPARISON OF CONVENTIONAL LIVE CELLS AND CFPS SYSTEMS 63
5.2.3 RESTRAINTS 64
5.2.3.1 High cost of essential reagents 64
5.2.4 OPPORTUNITIES 65
5.2.4.1 Integration of cell-free technology in biosensor development 65
5.2.4.2 Role in precision/personalized medicine 65
5.2.5 CHALLENGES 66
5.2.5.1 Inability to fully replicate complex mammalian post-translational modifications 66
5.2.5.2 Concerns regarding scaling up 66
5.3 INDUSTRY TRENDS 67
5.3.1 AI-GUIDED PROTEIN DESIGN PAIRED WITH CFPS FOR FASTER DISCOVERY 67
5.3.2 SCALE-UP VIA CDMO PARTNERSHIPS TOWARD GMP READINESS 68
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68
5.5 PRICING ANALYSIS 69
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER 69
5.5.2 AVERAGE SELLING PRICE RANGE OF KEY PRODUCTS, BY REGION 70
5.5.3 FACTORS IMPACTING CELL-FREE PROTEIN SYNTHESIS PRODUCT PRICING 70
5.6 TECHNOLOGY ANALYSIS 71
5.6.1 KEY TECHNOLOGIES 71
5.6.1.1 Cell-free protein synthesis (CFPS) 71
5.6.1.2 Coupled transcription/translation 71
5.6.2 COMPLEMENTARY TECHNOLOGIES 72
5.6.2.1 Synthetic DNA/mRNA & IVT capping–tailing 72
5.6.2.2 Membrane mimetics for CFPS 72
5.6.3 ADJACENT TECHNOLOGIES 72
5.6.3.1 Recombinant DNA Technology 72
5.7 TECHNOLOGY/PRODUCT ROADMAP 73
5.8 SUSTAINABILITY INITIATIVES 73
5.9 VALUE CHAIN ANALYSIS 73
5.10 ECOSYSTEM ANALYSIS 75
5.10.1 CELL-FREE PROTEIN SYNTHESIS MARKET: ROLE OF COMPANIES
IN ECOSYSTEM 76
5.11 PORTER’S FIVE FORCES ANALYSIS 77
5.11.1 THREAT OF NEW ENTRANTS 78
5.11.2 THREAT OF SUBSTITUTES 78
5.11.3 BARGAINING POWER OF SUPPLIERS 78
5.11.4 BARGAINING POWER OF BUYERS 78
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.12 PATENT ANALYSIS 78
5.12.1 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR CELL-
FREE PROTEIN SYNTHESIS PATENTS 79
5.12.2 LIST OF KEY PATENTS 80
5.13 REGULATORY LANDSCAPE 80
5.13.1 REGULATORY FRAMEWORK 80
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
5.13.2.1 North America 81
5.13.2.2 Europe 81
5.13.2.3 Asia Pacific 82
5.13.2.4 Rest of the World 83
5.14 KEY CONFERENCES & EVENTS 83
5.15 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 84
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
5.15.2 BUYING CRITERIA FOR CELL-FREE PROTEIN SYNTHESIS PRODUCTS 85
5.15.3 ADOPTION BARRIER AND INTERNAL FRICTION 86
5.16 INVESTMENT/FUNDING ACTIVITY 86
5.17 IMPACT OF AI/GEN AI ON CELL-FREE PROTEIN SYNTHESIS MARKET 87
5.17.1 INTRODUCTION 87
5.17.2 AI USE CASES 87
5.17.3 FUTURE OF GENERATIVE AI IN DRUG DEVELOPMENT ECOSYSTEM 87
5.18 IMPACT OF 2025 TRUMP TARIFF ON CELL-FREE PROTEIN SYNTHESIS MARKET 88
5.18.1 INTRODUCTION 88
5.18.2 KEY TARIFF RATES 88
5.18.3 PRICE IMPACT ANALYSIS 88
5.18.4 IMPACT ON REGION 89
5.18.4.1 North America 89
5.18.4.2 Europe 89
5.18.4.3 Asia Pacific 89
5.18.5 IMPACT ON END-USERS 90
5.18.5.1 Pharmaceutical & biotechnology companies 90
5.18.5.2 Academic & research institutes 90
5.18.5.3 CROs and CDMOs 91
5.18.5.4 Diagnostic companies 91
6 CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING 92
6.1 INTRODUCTION 93
6.2 PRODUCTS 93
6.2.1 KITS & REAGENTS 96
6.2.1.1 Increasing adoption in academic and commercial R&D to aid growth 96
6.2.2 CELL EXTRACTS & EXPRESSION SYSTEMS 98
6.2.2.1 Wheat germ 101
6.2.2.2 Rabbit reticulocyte 103
6.2.2.3 Mammalian 106
6.2.2.4 Insect 108
6.2.2.5 Plant/algal systems 111
6.2.3 INSTRUMENTS 113
6.3 SERVICES 115
7 CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW 118
7.1 INTRODUCTION 119
7.2 REACTION SETUP 119
7.2.1 USE OF CORE EXTRACTS IN THIS FOUNDATIONAL WORKFLOW STEP TO ACCELERATE ADOPTION 119
7.3 TRANSCRIPTION & TRANSLATION 122
7.3.1 STRONG ADOPTION OF COUPLED TX/TL TO SUPPORT GROWTH 122
7.4 PROTEIN FOLDING/POST-TRANSLATIONAL MODIFICATIONS (PTMS) 124
7.4.1 FOCUSING SHIFT TOWARDS COMPLEX TARGETS TO DRIVE SPENDING 124
7.5 TEMPLATE PREPARATION 127
7.5.1 GROWTH IN OUTSOURCED AND IN-HOUSE DNA SYNTHESIS TO DRIVE GROWTH 127
7.6 RECOVERY & PURIFICATION 129
7.6.1 READY-TO-RUN PURIFICATION MODULES CAN HELP VENDORS DIFFERENTIATE IN THE MARKET 129
7.7 VALIDATION & ANALYSIS 132
7.7.1 IMPORTANT STEP TO CONFIRM EXPRESSION, PURITY, IDENTITY, AND FUNCTION, ALLOWING TEAMS TO MAKE GO/NO-GO DECISIONS 132
8 CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD 135
8.1 INTRODUCTION 136
8.2 COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD 136
8.2.1 METHOD ENABLING SIMULTANEOUS SYNTHESIS OF MRNA AND PROTEIN IN SINGLE REACTION 136
8.3 TRANSCRIPTION & TRANSLATION 139
8.3.1 TWO-STEP APPROACH SHORTENED DESIGN-TO-DATA PROCESS WHILE PROVIDING TIGHTER CONTROL OVER PRODUCT QUALITY 139
9 CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION 142
9.1 INTRODUCTION 143
9.2 ENZYME ENGINEERING 143
9.2.1 RISING DEMAND FOR GREENER CHEMISTRIES TO AID GROWTH 143
9.3 HIGH THROUGHPUT PRODUCTION 146
9.3.1 HT CFPS SET TO BECOME THE DEFAULT ENGINE FOR PARALLEL PROTOTYPING AND RAPID METHOD TRANSFER INTO DOWNSTREAM MANUFACTURING 146
9.4 PROTEIN–PROTEIN INTERACTION 148
9.4.1 GROWING STUDIES DEMANDING PPI UNDERSTANDING AND COMPATIBILITY OF CFPS WITH MULTIPLEXED FORMATS TO AID GROWTH 148
9.5 PROTEIN LABELING 151
9.5.1 DEMAND FOR SITE-SPECIFIC TAGS, AND RAPID ANALYTICS TO ACCELERATE ADOPTION 151
9.6 PROTEIN PURIFICATION 153
9.6.1 RISE IN DEMAND FOR RAPID ACCESS TO PURIFIED PROTEINS TO
SUPPORT GROWTH 153
10 CELL-FREE PROTEIN SYNTHESIS MARKET, BY END USER 156
10.1 INTRODUCTION 157
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 157
10.2.1 GROWING DEMAND FOR COMPRESSING TIMELINES AND EXPANDING COMPLEX BIOLOGICS TO DRIVE GROWTH 157
10.3 ACADEMIC RESEARCH INSTITUTES 160
10.3.1 INCREASING DEMAND FOR INNOVATIVE RESEARCH SOLUTIONS TO SUPPORT GROWTH 160
10.4 CROS AND CDMOS 162
10.4.1 FASTER STUDY CYCLES, AND STREAMLINING STUDY STARTS TO DRIVE SEGMENT 162
10.5 DIAGNOSTIC COMPANIES 165
10.5.1 GROWING INTEREST IN CFPS-BASED DIAGNOSTICS FOR PATHOGEN OR BIOMARKER DETECTION TO SUPPORT GROWTH 165
11 CELL-FREE PROTEIN SYNTHESIS MARKET, BY REGION 168
11.1 INTRODUCTION 169
11.2 NORTH AMERICA 169
11.2.1 US 173
11.2.1.1 Rising approvals of protein-based therapies and increasing investments in R&D to support growth 173
11.2.2 CANADA 176
11.2.2.1 Government funding for research and innovation to support market growth 176
11.3 EUROPE 179
11.3.1 GERMANY 182
11.3.1.1 Presence of major research institutes and pharmaceutical companies to support growth 182
11.3.2 UK 185
11.3.2.1 Strong commercial support for research & development work by government, especially in life sciences, to drive growth 185
11.3.3 FRANCE 188
11.3.3.1 Rise in proteomics research in France to support growth 188
11.3.4 ITALY 191
11.3.4.1 Growth in Italian market to be driven by increase in life science research projects 191
11.3.5 SPAIN 194
11.3.5.1 Presence of established network of research centers and universities, with collaborations in biomedicine & health and physical sciences & engineering, to support growth 194
11.3.6 REST OF EUROPE (ROE) 197
11.4 ASIA PACIFIC 200
11.4.1 CHINA 204
11.4.1.1 Growth in proteomics R&D and growing pharmaceutical industry to support growth 204
11.4.2 JAPAN 207
11.4.2.1 Increasing protein-based research to support market growth 207
11.4.3 INDIA 210
11.4.3.1 Increasing drug development outsourcing to support market growth 210
11.4.4 AUSTRALIA 213
11.4.4.1 Growing precision medicine research to offer significant growth opportunities in Australia 213
11.4.5 SOUTH KOREA 216
11.4.5.1 Advancements in biopharmaceutical research and the development of novel therapies to support market growth 216
11.4.6 REST OF ASIA PACIFIC (ROAPAC) 219
11.5 LATIN AMERICA 222
11.5.1 BRAZIL 225
11.5.1.1 Industrial investment in protein sector to support market growth 225
11.5.2 MEXICO 228
11.5.2.1 Growth in biotechnology and pharmaceutical sectors to support growth 228
11.5.3 REST OF LATIN AMERICA 231
11.6 MIDDLE EAST 234
11.6.1 GCC COUNTRIES 237
11.6.2 REST OF MIDDLE EAST 239
11.6.3 AFRICA 242
11.6.3.1 Government investments in healthcare to drive market
growth in region 242
12 COMPETITIVE LANDSCAPE 252
12.1 INTRODUCTION 252
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 252
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS MARKET 252
12.3 REVENUE ANALYSIS, 2022–2024 254
12.4 MARKET SHARE ANALYSIS, 2024 254
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 257
12.5.1 STARS 257
12.5.2 EMERGING LEADERS 257
12.5.3 PERVASIVE PLAYERS 257
12.5.4 PARTICIPANTS 257
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS 259
12.5.5.1 Company footprint 259
12.5.5.2 Regional footprint 259
12.5.5.3 Offering footprint 260
12.5.5.4 Method footprint 261
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 261
12.6.1 PROGRESSIVE COMPANIES 261
12.6.2 RESPONSIVE COMPANIES 261
12.6.3 DYNAMIC COMPANIES 262
12.6.4 STARTING BLOCKS 262
12.6.5 COMPETITIVE BENCHMARKING 263
12.6.5.1 Detailed list of key startups/SMEs 263
12.6.5.2 Competitive benchmarking of startups/SMEs 263
12.7 COMPANY VALUATION & FINANCIAL METRICS 264
12.7.1 FINANCIAL METRICS 264
12.7.2 COMPANY VALUATION 264
12.8 BRAND/PRODUCT COMPARISON 265
12.9 COMPETITIVE SCENARIO 266
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 266
12.9.2 DEALS 266
12.9.3 EXPANSIONS 267
12.9.4 OTHER DEVELOPMENTS 267
13 COMPANY PROFILES 268
13.1 INTRODUCTION 268
13.2 KEY PLAYERS 268
13.2.1 NEW ENGLAND BIOLABS 268
13.2.1.1 Business overview 268
13.2.1.2 Products/ Services offered 269
13.2.1.3 Recent developments 269
13.2.1.3.1 Expansions 269
13.2.1.4 MnM view 269
13.2.1.4.1 Key strengths 269
13.2.1.4.2 Strategic choices 270
13.2.1.4.3 Weaknesses and competitive threats 270
13.2.2 PROMEGA CORPORATION 271
13.2.2.1 Business overview 271
13.2.2.2 Products/ Services offered 271
13.2.2.3 MnM view 272
13.2.2.3.1 Key strengths 272
13.2.2.3.2 Strategic choices 272
13.2.2.3.3 Weaknesses and competitive threats 272
13.2.3 THERMO FISHER SCIENTIFIC INC. 273
13.2.3.1 Business overview 273
13.2.3.2 Products/ Services offered 274
13.2.3.3 Recent developments 275
13.2.3.3.1 Deals 275
13.2.3.4 MnM view 275
13.2.3.4.1 Key strengths 275
13.2.3.4.2 Strategic choices 275
13.2.3.4.3 Weaknesses and competitive threats 276
13.2.4 GENSCRIPT 277
13.2.4.1 Business overview 277
13.2.4.2 Products/ Services offered 278
13.2.5 TAKARA BIO INC. 279
13.2.5.1 Business overview 279
13.2.5.2 Products/ Services offered 280
13.2.6 LENIOBIO GMBH 282
13.2.6.1 Business overview 282
13.2.6.2 Products/ Services offered 282
13.2.6.3 Recent developments 282
13.2.6.3.1 Deals 282
13.2.6.3.2 Other developments 283
13.2.7 CREATIVE BIOLABS 284
13.2.7.1 Business overview 284
13.2.7.2 Products/ Services offered 284
13.2.8 JENA BIOSCIENCE GMBH 285
13.2.8.1 Business overview 285
13.2.8.2 Products/ Services offered 285
13.2.9 BIOTECHRABBIT 286
13.2.9.1 Business overview 286
13.2.9.2 Products/ Services offered 286
13.2.10 BIODISCOVERY LLC 287
13.2.10.1 Business overview 287
13.2.10.2 Products/ Services offered 287
13.2.10.3 Recent developments 288
13.2.10.3.1 Product launches 288
13.2.10.3.2 Deals 288
13.2.11 BIONEER CORPORATION 289
13.2.11.1 Business overview 289
13.2.11.2 Products/ Services offered 289
13.2.12 SINO BIOLOGICAL, INC. 290
13.2.12.1 Business overview 290
13.2.12.2 Products/ Services offered 290
13.2.12.3 Recent developments 290
13.2.12.3.1 Deals 290
13.2.13 KANEKA CORPORATION 291
13.2.13.1 Business overview 291
13.2.13.2 Products/ Services offered 291
13.2.13.3 Recent developments 292
13.2.13.3.1 Product launches 292
13.2.14 GENECOPOEIA, INC. 293
13.2.14.1 Business overview 293
13.2.14.2 Products/ Services offered 293
13.2.15 CELLFREE SCIENCES CO., LTD. 294
13.2.15.1 Business overview 294
13.2.15.2 Products/ Services offered 294
13.2.15.3 Recent developments 294
13.2.15.3.1 Deals 294
13.3 OTHER PLAYERS 295
13.3.1 VECTORBUILDER INC. 295
13.3.2 EXCELLGEN, INC. 295
13.3.3 CD BIOSYNSIS 296
13.3.4 CREATIVE BIOGENE 296
13.3.5 CUSABIO TECHNOLOGY 297
13.3.6 PROFACGEN 297
13.3.7 CAYMAN CHEMICAL 298
13.3.8 CAMBRIDGE ISOTOPE LABORATORIES, INC. 298
13.3.9 SYNTHELIS BIOTECH 299
13.3.10 SYNBIO TECHNOLOGIES 299
13.3.11 AMSBIO 300
14 APPENDIX 301
14.1 DISCUSSION GUIDE 301
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 305
14.3 CUSTOMIZATION OPTIONS 307
14.4 RELATED REPORTS 307
14.5 AUTHOR DETAILS 308
LIST OF TABLES
TABLE 1 INCLUSIONS AND EXCLUSIONS 36
TABLE 2 IMPACT ANALYSIS OF SUPPLY– AND DEMAND–SIDE FACTORS 46
TABLE 3 CELL-FREE PROTEIN SYNTHESIS MARKET: RISK ANALYSIS 49
TABLE 4 CELL-FREE PROTEIN SYNTHESIS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS 60
TABLE 5 CELL-FREE PROTEIN SYNTHESIS MARKET: IMPACT ANALYSIS 62
TABLE 6 COMPARISON OF CONVENTIONAL LIVE CELLS AND CFPS SYSTEMS 63
TABLE 7 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER, 2024 (USD) 69
TABLE 8 AVERAGE SELLING PRICE RANGE OF KEY PRODUCTS, BY REGION,
2024–2025 (USD) 70
TABLE 9 CELL-FREE PROTEIN SYNTHESIS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 76
TABLE 10 CELL-FREE PROTEIN SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS 77
TABLE 11 CELL-FREE PROTEIN SYNTHESIS MARKET: DETAILED ANALYSIS OF KEY PATENTS, 2023–2025 80
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 81
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 81
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 16 CELL-FREE PROTEIN SYNTHESIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 83
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 84
TABLE 18 BUYING CRITERIA FOR CELL-FREE PROTEIN SYNTHESIS PRODUCTS, BY END USER 85
TABLE 19 CELL-FREE PROTEIN SYNTHESIS: ADOPTION BARRIER & INTERNAL FRICTION 86
TABLE 20 CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERINGS,
2023–2030 (USD MILLION) 93
TABLE 21 CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY TYPE,
2023–2030 (USD MILLION) 93
TABLE 22 CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY REGION,
2023–2030 (USD MILLION) 94
TABLE 23 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 24 EUROPE: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 25 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 26 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 27 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 95
TABLE 28 CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET, BY REGION,
2023–2030 (USD MILLION) 96
TABLE 29 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 30 EUROPE: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 31 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 32 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 33 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 98
TABLE 34 CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 99
TABLE 35 NORTH AMERICA: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 36 EUROPE: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 37 ASIA PACIFIC: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 38 LATIN AMERICA: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 39 MIDDLE EAST: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 100
TABLE 40 WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 101
TABLE 41 NORTH AMERICA: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 42 EUROPE: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 43 ASIA PACIFIC: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 44 LATIN AMERICA: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 45 MIDDLE EAST: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 103
TABLE 46 RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 104
TABLE 47 NORTH AMERICA: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 48 EUROPE: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 49 ASIA PACIFIC: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 50 LATIN AMERICA: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 51 MIDDLE EAST: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 105
TABLE 52 MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 106
TABLE 53 NORTH AMERICA: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 54 EUROPE: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 55 ASIA PACIFIC: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 56 LATIN AMERICA: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 57 MIDDLE EAST: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 108
TABLE 58 INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET,
BY REGION, 2023–2030 (USD MILLION) 109
TABLE 59 NORTH AMERICA: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 60 EUROPE: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024–2033 (USD MILLION) 109
TABLE 61 ASIA PACIFIC: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 62 LATIN AMERICA: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 63 MIDDLE EAST: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 110
TABLE 64 PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2024–2033 (USD MILLION) 111
TABLE 65 NORTH AMERICA: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024–2033 (USD MILLION) 111
TABLE 66 EUROPE: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024–2033 (USD MILLION) 112
TABLE 67 ASIA PACIFIC: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024–2033 (USD MILLION) 112
TABLE 68 LATIN AMERICA: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 69 MIDDLE EAST: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 113
TABLE 70 CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY REGION,
2023–2030 (USD MILLION) 113
TABLE 71 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 72 EUROPE: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 73 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 74 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 75 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 115
TABLE 76 CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 77 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 78 EUROPE: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 79 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 80 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 81 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 117
TABLE 82 CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 119
TABLE 83 CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY REGION,
2023–2030 (USD MILLION) 120
TABLE 84 NORTH AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 85 EUROPE: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 86 ASIA PACIFIC: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 87 LATIN AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 88 MIDDLE EAST: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 121
TABLE 89 CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY REGION, 2023–2030 (USD MILLION) 122
TABLE 90 NORTH AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 91 EUROPE: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 92 ASIA PACIFIC: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 93 LATIN AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 94 MIDDLE EAST: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 124
TABLE 95 CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 96 NORTH AMERICA: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 97 EUROPE: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 98 ASIA PACIFIC: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 99 LATIN AMERICA: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 100 MIDDLE EAST: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 126
TABLE 101 CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY REGION,
2023–2030 (USD MILLION) 127
TABLE 102 NORTH AMERICA: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 103 EUROPE: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 104 ASIA PACIFIC: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 105 LATIN AMERICA: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 106 MIDDLE EAST: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 129
TABLE 107 CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY REGION,
2023–2030 (USD MILLION) 130
TABLE 108 NORTH AMERICA: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 109 EUROPE: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 110 ASIA PACIFIC: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 111 LATIN AMERICA: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 112 MIDDLE EAST: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 131
TABLE 113 CELL-FREE PROTEIN VALIDATION AND ANALYSIS MARKET, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 114 NORTH AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 115 EUROPE: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 116 ASIA PACIFIC: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET,
BY COUNTRY, 2024–2033 (USD MILLION) 133
TABLE 117 LATIN AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 118 CELL-FREE PROTEIN VALIDATION AND ANALYSIS MARKET, BY SUBREGION,
2023–2030 (USD MILLION) 134
TABLE 119 CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD MARKET, BY METHOD, 2023–2030 (USD MILLION) 136
TABLE 120 CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD MARKET, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 121 NORTH AMERICA: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 122 EUROPE: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 123 ASIA PACIFIC: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 124 LATIN AMERICA: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 125 MIDDLE EAST: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX–TL) METHOD MARKET, BY SUBREGION, 2023–2030 (USD MILLION) 138
TABLE 126 CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 127 NORTH AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 128 EUROPE: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 129 ASIA PACIFIC: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 130 LATIN AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 131 MIDDLE EAST: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET,
BY SUBREGION, 2023–2030 (USD MILLION) 141
TABLE 132 CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2024–2033 (USD MILLION) 143
TABLE 133 CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING,
BY REGION, 2023–2030 (USD MILLION) 144
TABLE 134 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 135 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING,
BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 136 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 137 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 138 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY SUBREGION, 2023–2030 (USD MILLION) 145
TABLE 139 CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION,
BY REGION, 2023–2030 (USD MILLION) 146
TABLE 140 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 141 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 142 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 143 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 144 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY SUBREGION, 2023–2030 (USD MILLION) 148
TABLE 145 CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN–PROTEIN INTERACTION,
BY REGION, 2023–2030 (USD MILLION) 149
TABLE 146 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN–PROTEIN INTERACTION, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 147 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN–PROTEIN INTERACTION, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 148 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN–PROTEIN INTERACTION, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 149 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN–PROTEIN INTERACTION, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 150 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PROTEIN–PROTEIN INTERACTION, BY SUBREGION, 2023–2030 (USD MILLION) 150
TABLE 151 CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 152 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 153 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING,
BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 154 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING,
BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 155 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 156 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY SUBREGION, 2023–2030 (USD MILLION) 153
TABLE 157 CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY REGION, 2023–2030 (USD MILLION) 154
TABLE 158 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 159 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION,
BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 160 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 161 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 162 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY SUBREGION, 2023–2030 (USD MILLION) 155
TABLE 163 CELL-FREE PROTEIN SYNTHESIS MARKET, BY END USER,
2023–2030 (USD MILLION) 157
TABLE 164 CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 158
TABLE 165 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2023–2030 (USD MILLION) 158
TABLE 166 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 167 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 168 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 169 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY SUBREGION, 2023–2030 (USD MILLION) 159
TABLE 170 CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 160
TABLE 171 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 172 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 161
TABLE 173 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 161
TABLE 174 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 175 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY SUBREGION, 2023–2030 (USD MILLION) 162
TABLE 176 CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY REGION, 2023–2030 (USD MILLION) 163
TABLE 177 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 178 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS,
BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 179 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 180 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 181 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY SUBREGION, 2023–2030 (USD MILLION) 164
TABLE 182 CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY REGION, 2023–2030 (USD MILLION) 165
TABLE 183 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 184 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 185 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 186 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 187 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY SUBREGION, 2023–2030 (USD MILLION) 167
TABLE 188 CELL-FREE PROTEIN SYNTHESIS MARKET, BY REGION, 2023–2030 (USD MILLION) 169
TABLE 189 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 170
TABLE 190 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 171
TABLE 191 NORTH AMERICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 192 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 171
TABLE 193 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 172
TABLE 194 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172
TABLE 195 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 172
TABLE 196 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 173
TABLE 197 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 173
TABLE 198 US: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 199 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 174
TABLE 200 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 175
TABLE 201 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 175
TABLE 202 US: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2
023–2030 (USD MILLION) 175
TABLE 203 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 177
TABLE 204 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 177
TABLE 205 CANADA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 206 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 178
TABLE 207 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 178
TABLE 208 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 179
TABLE 209 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 179
TABLE 210 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 180
TABLE 211 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 180
TABLE 212 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY CELL EXTRACTS & EXPRESSION SYSTEM, 2023–2030 (USD MILLION) 181
TABLE 213 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 181
TABLE 214 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 181
TABLE 215 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 182
TABLE 216 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 182
TABLE 217 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 183
TABLE 218 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 183
TABLE 219 GERMANY: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 220 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 184
TABLE 221 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 184
TABLE 222 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 185
TABLE 223 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 185
TABLE 224 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 186
TABLE 225 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 186
TABLE 226 UK: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 227 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 187
TABLE 228 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 187
TABLE 229 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 187
TABLE 230 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 188
TABLE 231 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 189
TABLE 232 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 233 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY CELL EXTRACTS & EXPRESSION SYSTEM, 2023–2030 (USD MILLION) 189
TABLE 234 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 190
TABLE 235 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 190
TABLE 236 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 190
TABLE 237 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 191
TABLE 238 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 192
TABLE 239 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 192
TABLE 240 ITALY: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2024–2033 (USD MILLION) 192
TABLE 241 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 193
TABLE 242 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 193
TABLE 243 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 193
TABLE 244 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 194
TABLE 245 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 195
TABLE 246 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 195
TABLE 247 SPAIN: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2024–2033 (USD MILLION) 195
TABLE 248 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 196
TABLE 249 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 196
TABLE 250 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 197
TABLE 251 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 197
TABLE 252 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 198
TABLE 253 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 198
TABLE 254 REST OF EUROPE: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 255 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 199
TABLE 256 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 199
TABLE 257 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 200
TABLE 258 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 200
TABLE 259 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 202
TABLE 260 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 202
TABLE 261 ASIA PACIFIC: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 262 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 203
TABLE 263 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 203
TABLE 264 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 203
TABLE 265 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 204
TABLE 266 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 205
TABLE 267 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 205
TABLE 268 CHINA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 269 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 206
TABLE 270 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 206
TABLE 271 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 206
TABLE 272 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 207
TABLE 273 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 208
TABLE 274 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 208
TABLE 275 JAPAN: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 276 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 209
TABLE 277 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 209
TABLE 278 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 209
TABLE 279 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 210
TABLE 280 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 211
TABLE 281 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 211
TABLE 282 INDIA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2024–2033 (USD MILLION) 211
TABLE 283 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 212
TABLE 284 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 212
TABLE 285 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 212
TABLE 286 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 213
TABLE 287 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 214
TABLE 288 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 214
TABLE 289 AUSTRALIA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2024–2033 (USD MILLION) 214
TABLE 290 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 215
TABLE 291 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2024–2033 (USD MILLION) 215
TABLE 292 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 216
TABLE 293 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 216
TABLE 294 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 217
TABLE 295 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 217
TABLE 296 SOUTH KOREA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024–2033 (USD MILLION) 217
TABLE 297 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 218
TABLE 298 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 218
TABLE 299 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 218
TABLE 300 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 219
TABLE 301 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 219
TABLE 302 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 220
TABLE 303 REST OF ASIA PACIFIC: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 304 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 221
TABLE 305 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023–2030 (USD MILLION) 221
TABLE 306 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 222
TABLE 307 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023–2030 (USD MILLION) 222
TABLE 308 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 223
TABLE 309 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 223
TABLE 310 LATIN AMERICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024–2033 (USD MILLION) 224
TABLE 311 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 224
TABLE 312 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 224
TABLE 313 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225
TABLE 314 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 225
TABLE 315 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 226
TABLE 316 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 226
TABLE 317 BRAZIL: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2024–2033 (USD MILLION) 226
TABLE 318 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2024–2033 (USD MILLION) 227
TABLE 319 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 227
TABLE 320 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 228
TABLE 321 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 228
TABLE 322 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 229
TABLE 323 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 229
TABLE 324 MEXICO: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 325 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 230
TABLE 326 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 230
TABLE 327 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 231
TABLE 328 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 231
TABLE 329 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 232
TABLE 330 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 232
TABLE 331 REST OF LATIN AMERICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 332 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET,
BY WORKFLOW, 2023–2030 (USD MILLION) 233
TABLE 333 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET,
BY METHOD, 2023–2030 (USD MILLION) 233
TABLE 334 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 233
TABLE 335 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023–2030 (USD MILLION) 234
TABLE 336 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 234
TABLE 337 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2024–2033 (USD MILLION) 235
TABLE 338 MIDDLE EAST: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 339 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 235
TABLE 340 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 236
TABLE 341 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 236
TABLE 342 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 236
TABLE 343 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 237
TABLE 344 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 237
TABLE 345 GCC COUNTRIES: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 346 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 238
TABLE 347 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 238
TABLE 348 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239
TABLE 349 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 239
TABLE 350 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 240
TABLE 351 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 240
TABLE 352 REST OF MIDDLE EAST: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 353 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 241
TABLE 354 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023–2030 (USD MILLION) 241
TABLE 355 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 242
TABLE 356 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET,
END USER, 2023–2030 (USD MILLION) 242
TABLE 357 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2023–2030 (USD MILLION) 243
TABLE 358 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 243
TABLE 359 AFRICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 360 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2023–2030 (USD MILLION) 244
TABLE 361 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2023–2030 (USD MILLION) 244
TABLE 362 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 244
TABLE 363 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER,
2023–2030 (USD MILLION) 245
TABLE 364 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 245
TABLE 365 EUROPE: KEY MACROECONOMIC INDICATORS 246
TABLE 366 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 248
TABLE 367 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 249
TABLE 368 MIDDLE EAST: KEY MACROECONOMIC INDICATORS 250
TABLE 369 AFRICA: KEY MACRO INDICATORS 251
TABLE 370 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS MARKET, JANUARY 2021—OCTOBER 2025 252
TABLE 371 CELL-FREE PROTEIN SYNTHESIS MARKET: DEGREE OF COMPETITION 255
TABLE 372 CELL-FREE PROTEIN SYNTHESIS MARKET: REGIONAL FOOTPRINT, 2024 259
TABLE 373 CELL-FREE PROTEIN SYNTHESIS MARKET: OFFERING FOOTPRINT, 2024 260
TABLE 374 CELL-FREE PROTEIN SYNTHESIS MARKET: METHOD FOOTPRINT, 2024 261
TABLE 375 CRO SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS, 2024 263
TABLE 376 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERINGS AND REGION 263
TABLE 377 CELL-FREE PROTEIN SYNTHESIS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–OCTOBER 2025 266
TABLE 378 CELL-FREE PROTEIN SYNTHESIS MARKET: DEALS, JANUARY 2021–OCTOBER 2025 266
TABLE 379 CELL-FREE PROTEIN SYNTHESIS MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2025 267
TABLE 380 CELL-FREE PROTEIN SYNTHESIS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2025 267
TABLE 381 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 268
TABLE 382 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED 269
TABLE 383 NEW ENGLAND BIOLABS: EXPANSIONS 269
TABLE 384 PROMEGA CORPORATION: COMPANY OVERVIEW 271
TABLE 385 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 271
TABLE 386 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 273
TABLE 387 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 274
TABLE 388 THERMO FISHER SCIENTIFIC INC.: DEALS 275
TABLE 389 GENSCRIPT: COMPANY OVERVIEW 277
TABLE 390 GENSCRIPT: PRODUCTS/SERVICES OFFERED 278
TABLE 391 TAKARA BIO INC.: COMPANY OVERVIEW 279
TABLE 392 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 280
TABLE 393 LENIOBIO GMBH: COMPANY OVERVIEW 282
TABLE 394 LENIOBIO GMBH: PRODUCTS/SERVICES OFFERED 282
TABLE 395 LENIOBIO GMBH: DEALS 282
TABLE 396 LENIOBIO GMBH: OTHER DEVELOPMENTS 283
TABLE 397 CREATIVE BIOLABS: COMPANY OVERVIEW 284
TABLE 398 CREATIVE BIOLABS: PRODUCTS/SERVICES OFFERED 284
TABLE 399 JENA BIOSCIENCE GMBH: COMPANY OVERVIEW 285
TABLE 400 JENA BIOSCIENCE GMBH: PRODUCTS/SERVICES OFFERED 285
TABLE 401 BIOTECHRABBIT: COMPANY OVERVIEW 286
TABLE 402 BIOTECHRABBIT: PRODUCTS/SERVICES OFFERED 286
TABLE 403 BIODISCOVERY LLC: COMPANY OVERVIEW 287
TABLE 404 BIODISCOVERY LLC: PRODUCTS/SERVICES OFFERED 287
TABLE 405 BIODISCOVERY LLC: PRODUCT LAUNCHES 288
TABLE 406 BIODISCOVERY LLC: DEALS 288
TABLE 407 BIONEER CORPORATION: COMPANY OVERVIEW 289
TABLE 408 BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED 289
TABLE 409 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW 290
TABLE 410 SINO BIOLOGICAL, INC.: SERVICES OFFERED 290
TABLE 411 SINO BIOLOGICAL, INC.: DEALS 290
TABLE 412 KANEKA CORPORATION: COMPANY OVERVIEW 291
TABLE 413 KANEKA CORPORATION: PRODUCTS/SERVICES OFFERED 291
TABLE 414 KANEKA CORPORATION: PRODUCT LAUNCHES 292
TABLE 415 GENECOPOEIA, INC.: COMPANY OVERVIEW 293
TABLE 416 GENECOPOEIA, INC.: PRODUCTS/SERVICES OFFERED 293
TABLE 417 CELLFREE SCIENCES CO., LTD.: COMPANY OVERVIEW 294
TABLE 418 CELLFREE SCIENCES CO., LTD.: PRODUCTS/SERVICES OFFERED 294
TABLE 419 CELLFREE SCIENCES CO., LTD.: DEALS 294
TABLE 420 VECTORBUILDER INC.: COMPANY OVERVIEW 295
TABLE 421 EXCELLGEN, INC.: COMPANY OVERVIEW 295
TABLE 422 CD BIOSYNSIS: COMPANY OVERVIEW 296
TABLE 423 CREATIVE BIOGENE: COMPANY OVERVIEW 296
TABLE 424 CUSABIO TECHNOLOGY: COMPANY OVERVIEW 297
TABLE 425 PROFACGEN: COMPANY OVERVIEW 297
TABLE 426 CAYMAN CHEMICAL: COMPANY OVERVIEW 298
TABLE 427 CAMBRIDGE ISOTOPE LABORATORIES, INC.: COMPANY OVERVIEW 298
TABLE 428 SYNTHELIS BIOTECH: COMPANY OVERVIEW 299
TABLE 429 SYNBIO TECHNOLOGIES: COMPANY OVERVIEW 299
TABLE 430 AMSBIO: COMPANY OVERVIEW 300
LIST OF FIGURES
FIGURE 1 CELL-FREE PROTEIN SYNTHESIS MARKET SEGMENTATION 35
FIGURE 2 CELL-FREE PROTEIN SYNTHESIS MARKET SEGMENTATION 37
FIGURE 3 CELL-FREE PROTEIN SYNTHESIS MARKET: RESEARCH DESIGN 38
FIGURE 4 CELL-FREE PROTEIN SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS) 40
FIGURE 5 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET SIZE ESTIMATION
(SUPPLY-SIDE ANALYSIS), 2024 41
FIGURE 6 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET SIZE ESTIMATION:
COMPANY REVENUE ANALYSIS (BOTTOM–UP APPROACH), 2024 42
FIGURE 7 CELL-FREE PROTEIN SYNTHESIS MARKET SIZE VALIDATION FROM
INDUSTRY EXPERTS 43
FIGURE 8 SEGMENTAL MARKET SIZE ESTIMATION: TOP–DOWN APPROACH 44
FIGURE 9 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET: CAGR PROJECTIONS
(2025–2030) 45
FIGURE 10 CELL-FREE PROTEIN SYNTHESIS MARKET: DATA TRIANGULATION METHODOLOGY 47
FIGURE 11 CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING,
2025 VS. 2030 (USD MILLION) 50
FIGURE 12 CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW,
2025 VS. 2030 (USD MILLION) 51
FIGURE 13 CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD,
2025 VS. 2030 (USD MILLION) 51
FIGURE 14 CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 52
FIGURE 15 CELL-FREE PROTEIN SYNTHESIS MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 52
FIGURE 16 REGIONAL SNAPSHOT OF CELL-FREE PROTEIN SYNTHESIS MARKET 53
FIGURE 17 INCREASING DEMAND FOR RAPID PROTEIN SYNTHESIS FOR RESEARCH AND THERAPEUTIC APPLICATIONS TO PROPEL MARKET GROWTH 56
FIGURE 18 US AND ENZYME ENGINEERING SEGMENT COMMANDED LARGEST MARKET SHARES IN 2024 57
FIGURE 19 CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD 58
FIGURE 20 CELL-FREE PROTEIN SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
FIGURE 21 REVENUE SHIFT IN CELL-FREE PROTEIN SYNTHESIS MARKET 69
FIGURE 22 VALUE CHAIN ANALYSIS: PRODUCT DEVELOPMENT AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE 74
FIGURE 23 CELL-FREE PROTEIN SYNTHESIS MARKET: ECOSYSTEM ANALYSIS 75
FIGURE 24 CELL-FREE PROTEIN SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS 77
FIGURE 25 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR CELL-FREE PROTEIN SYNTHESIS PATENTS (JANUARY 2014–DECEMBER 2024) 79
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF CELL-FREE PROTEIN SYNTHESIS BASED ON OFFERINGS 84
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 85
FIGURE 28 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET SNAPSHOT 170
FIGURE 29 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET SNAPSHOT 201
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS
MARKET, 2022–2024 (USD MILLION) 254
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS MARKET, 2024 255
FIGURE 32 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 258
FIGURE 33 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPANY FOOTPRINT, 2024 259
FIGURE 34 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 262
FIGURE 35 EV/EBITDA OF KEY VENDORS 264
FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 264
FIGURE 37 CELL-FREE PROTEIN SYNTHESIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 265
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 274
FIGURE 39 GENSCRIPT: COMPANY SNAPSHOT 278
FIGURE 40 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 280
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11